Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.
Petros Pharmaceuticals has raised $9.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
Petros Pharmaceuticals's investors include Juggernaut Capital Partners.
Petros Pharmaceuticals is headquartered in New York, United States.
Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.
Petros Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Petros Pharmaceuticals — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/petros-pharmaceuticals. Accessed August 15, 2026.
VCBacked. (2025). Petros Pharmaceuticals — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/petros-pharmaceuticals
{{cite web |title=Petros Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/petros-pharmaceuticals |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated